Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

27
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
27
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

177
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
177
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

448
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
448
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

204
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
204
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.4K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.4K
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

148
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
148

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting ribonucleotide reductase to enhance the antileukemic activity of gilteritinib against chemoresistant <i>FLT3</i>- internal tandem duplication acute myeloid leukemia.

ASPET discovery·2026
Same authorSame journal

Optimizing Clinical Study Designs for CAR-T Cell Therapy: Development of an Efficient Sampling Strategy Through Optimal Experimental Design.

CPT: pharmacometrics & systems pharmacology·2026
Same author

MSTune: A Data-Driven Approach to Parameter Tuning Using Grid Search and Differential Evolution for Gas Chromatography-Mass Spectrometry-Based Compound Identification.

Metabolites·2026
Same author

Image-Guided Thermal Ablation of Stage 1 Single and Multiple Primary Lung Carcinoma: Five-Year Outcomes.

Medical sciences (Basel, Switzerland)·2026
Same author

Machine Learning-Enabled In Situ Diagnostics for Intelligent Plasma-Based Semiconductor Manufacturing: A Review.

ACS applied materials & interfaces·2026
Same author

A Novel Drug Candidate that Selectively Targets the Critical Androgen Receptor-ELK1 Growth Axis in Advanced and Drug-Resistant Prostate Cancer.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Oct 19, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K

Metaheuristics for pharmacometrics.

Seongho Kim1, Andrew C Hooker2, Yu Shi3

  • 1Department of Oncology, Wayne State University, Detroit, Michigan, USA.

CPT: Pharmacometrics & Systems Pharmacology
|September 25, 2021
PubMed
Summary
This summary is machine-generated.

This study explores nature-inspired metaheuristic algorithms, like particle swarm optimization (PSO), for complex pharmacometric problems. Hybridizing PSO with sparse grids enhances parameter estimation in nonlinear mixed-effects models, outperforming other methods.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.6K

Related Experiment Videos

Last Updated: Oct 19, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

18.9K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

32.6K

Area of Science:

  • Computational science
  • Pharmacometrics
  • Optimization algorithms

Background:

  • Metaheuristics are versatile optimization tools applicable across various scientific disciplines.
  • Nature-inspired metaheuristic algorithms offer flexibility for complex problems in computer science and engineering.
  • Hybridization of metaheuristics with other algorithms is a common strategy to improve performance.

Purpose of the Study:

  • To review metaheuristic algorithms and demonstrate their application in pharmacometrics.
  • To showcase the utility of particle swarm optimization (PSO) in estimating parameters for nonlinear mixed-effects models.
  • To introduce and evaluate a novel hybrid algorithm combining PSO with sparse grids for optimal experimental design.

Main Methods:

  • Review of metaheuristic algorithms and their properties.
  • Application of particle swarm optimization (PSO) for parameter estimation in nonlinear mixed-effects models.
  • Development and implementation of a hybrid PSO-sparse grid algorithm for efficient design of experiments.

Main Results:

  • PSO effectively estimates parameters in complex nonlinear mixed-effects models and addresses identifiability issues.
  • The hybrid PSO-sparse grid algorithm successfully identifies efficient designs for parameter estimation in count-based nonlinear mixed-effects models.
  • The proposed hybrid algorithm demonstrates superior performance compared to alternative methods, including adaptive Gaussian quadrature and other nature-inspired metaheuristics.

Conclusions:

  • Metaheuristic algorithms, particularly PSO, are valuable tools for addressing complex pharmacometric challenges.
  • Hybridization strategies, such as combining PSO with sparse grids, can significantly enhance the efficiency and effectiveness of optimization in pharmacometrics.
  • The developed hybrid algorithm offers a promising approach for optimizing experimental designs in nonlinear mixed-effects modeling, especially for count data.